Imagion Biosystems Limited
IBXXF
$0.01
$0.00-10.71%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -393.75% | -378.56% | -5.78% | -3.80% | 88.73% |
| Total Depreciation and Amortization | -44.00% | -46.15% | -98.89% | -98.89% | -98.72% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 264.46% | 259.42% | -111.86% | -111.63% | -166.23% |
| Change in Net Operating Assets | -821.36% | -800.29% | -- | -- | -95.20% |
| Cash from Operations | -104.96% | -98.71% | -1,001.16% | -980.43% | 51.50% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -50.00% |
| Total Debt Repaid | -- | -- | -- | -- | 89.80% |
| Issuance of Common Stock | 12.00% | 12.00% | -- | -- | 58.64% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -34.03% | -34.03% | -- | -- | 30.51% |
| Cash from Financing | -3.65% | -6.60% | -- | -- | 49.36% |
| Foreign Exchange rate Adjustments | -202.56% | -200.00% | -210.71% | -207.14% | 136.45% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -57.56% | -58.86% | -1,217.97% | -1,196.87% | 1,110.16% |